aTyr Pharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q2 2024 | 3 | -$0.27 | -$0.21 | -$0.24 |
| Q3 2024 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q4 2024 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q1 2025 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q2 2025 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q3 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
aTyr Pharma, Inc. Earnings Date And Information
aTyr Pharma, Inc. last posted its earnings results on Thursday, May 2nd, 2024. The company reported $-0.23 earnings per share for the quarter, topping analysts' consensus estimates of $-0.24 by $0.01. The company had revenue of 235,000 for the quarter and had revenue of 353,000 for the year. aTyr Pharma, Inc. has generated $-1 earnings per share over the last year ($-0.94 diluted earnings per share) and currently has a price-to-earnings ratio of -2.33. aTyr Pharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based on prior year's report dates.
aTyr Pharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/02/2024 | Q1 2024 | -$0.24 | -$0.23 | 0.01 | $36,667 | $235,000 |
| 03/14/2024 | Q4 2023 | -$0.23 | -$0.25 | -0.02 | $3.42 M | $4.32 M |
| 11/09/2023 | Q3 2023 | -$0.21 | -$0.20 | 0.01 | $353,000 | |
| 08/09/2023 | Q2 2023 | -$0.27 | -$0.22 | 0.05 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.39 | -$0.27 | 0.12 | $2.36 M | $0 |
| 03/14/2023 | Q4 2022 | -$0.24 | $357,143 | $10.39 M | ||
| 11/14/2022 | Q3 2022 | -$0.45 | $0 | |||
| 08/15/2022 | Q2 2022 | -$0.43 | -$0.44 | -0.01 | $0 | |
| 05/10/2022 | Q1 2022 | -$0.43 | $200,000 | $0 | ||
| 03/15/2022 | Q4 2021 | -$0.31 | $2.52 M | $0 | ||
| 11/12/2021 | Q3 2021 | -$0.42 | $0 | |||
| 08/11/2021 | Q2 2021 | -$0.64 | $0 | |||
| 05/14/2021 | Q1 2021 | -$0.51 | $3.98 M | $0 | ||
| 03/23/2021 | Q4 2020 | -$0.47 | $126,000 | $2.05 M | ||
| 11/13/2020 | Q3 2020 | -$0.68 | $148,000 | |||
| 08/13/2020 | Q2 2020 | -$0.73 | -$0.69 | 0.04 | $189,000 | |
| 05/12/2020 | Q1 2020 | -$0.18 | $0.25 | 0.43 | $4.40 M | $8.07 M |
| 03/26/2020 | Q4 2019 | -$1.59 | -$1.54 | 0.05 | $155,767 | $144,000 |
| 11/14/2019 | Q3 2019 | -$1.43 | -$1.47 | -0.04 | $184,000 | |
| 08/14/2019 | Q2 2019 | -$2.74 | -$1.80 | 0.94 | $94,000 |
aTyr Pharma, Inc. Earnings: Frequently Asked Questions
-
When is aTyr Pharma, Inc.'s earnings date?
aTyr Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates.
-
Did aTyr Pharma, Inc. beat their earnings estimates last quarter?
In the previous quarter, aTyr Pharma, Inc. (:LIFE) reported $-0.23 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.24 by $0.01.
-
How can I listen to aTyr Pharma, Inc.'s earnings conference call?
The conference call for aTyr Pharma, Inc.'s latest earnings report can be listened to online.
-
How can I read aTyr Pharma, Inc.'s conference call transcript?
The conference call transcript for aTyr Pharma, Inc.'s latest earnings report can be read online.
-
How much revenue does aTyr Pharma, Inc. generate each year?
aTyr Pharma, Inc. (:LIFE) has a recorded annual revenue of $353,000.
-
How much profit does aTyr Pharma, Inc. generate each year?
aTyr Pharma, Inc. (:LIFE) has a recorded net income of $353,000. aTyr Pharma, Inc. has generated $-0.94 earnings per share over the last four quarters.
-
What is aTyr Pharma, Inc.'s price-to-earnings ratio?
aTyr Pharma, Inc. (:LIFE) has a price-to-earnings ratio of -2.33 and price/earnings-to-growth ratio is -0.55.
